AW

Anita Wiebe

IG Immatics Biotechnologies Gmbh: 9 patents #10 of 51Top 20%
📍 Rötteln, DE: #8 of 65 inventorsTop 15%
Overall (2024): #12,258 of 561,600Top 3%
9
Patents 2024

Issued Patents 2024

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
12180256 Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers Oliver Schoor, Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh 2024-12-31
12150979 Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers Oliver Schoor, Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh 2024-11-26
12121572 Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Sarah Kutscher 2024-10-22
12097248 Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Sarah Kutscher 2024-09-24
12076380 Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Sarah Kutscher 2024-09-03
12070491 Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers Toni Weinschenk, Andrea Mahr, Jens Fritsche, Phillip Mueller, Sarah Kutscher 2024-08-27
12036271 Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers Andrea Mahr, Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh 2024-07-16
11897935 Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers Andrea Mahr, Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh 2024-02-13
11897936 Peptides, combination of peptides as targets and for use in immunotherapy Andrea Mahr, Toni Weinschenk, Oliver Schoor, Jens Fritsche, Harpreet Singh 2024-02-13